Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-6

  Abreu, Ana S ^a   Castanheira, Elisabete M S ^a   Queiroz, Maria João R P ^a   Ferreira, Paula M T ^a   Vale Silva, Luís A ^b   Pinto, Eugénia ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINES; CONTINUOUS EXPOSURE; DIHEXADECYL PHOSPHATE; DIPALMITOYL PHOSPHATIDYLCHOLINE; DYNAMIC LIGHT SCATTERING MEASUREMENT; ENCAPSULATED COMPOUNDS; GOOD STABILITY; GROWTH INHIBITION; HUMAN TUMOR CELLS; HYDRODYNAMIC DIAMETER; IN-VITRO; INDOLE DERIVATIVES; LIPID MEMBRANES; MONODISPERSE; NANO-SIZED; NANOLIPOSOMES; NON SMALL CELL LUNG CANCER; PHOSPHATIDYLGLYCEROLS; POTENTIAL VALUES;

CARBOXYLATION; CELL CULTURE; DIALYSIS; DIALYSIS MEMBRANES; LIPOSOMES; PHOSPHOLIPIDS; ZETA POTENTIAL;

CELLS;

EID: 84856065265     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-482     Document Type: Article

References (25)

1. Huynh NT, Passirani C, Saulnier P, Benoit JP: Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009, 379:201.
2. Mozafari MR, Mortazavi SM: Nanoliposomes: From Fundamental to Recent Developments. Victoria: Trafford; 2005.
3. Andresen TL, Jensen SS, Jorgensen K: Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005, 44:68.
4. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer-chemotherapy - mechanism of tumoritropic accumulation of proteins and the antitumor agents smancs. Cancer Res 1986, 46:6387.
5. Maeda H, Bharate GY, Daruwalla J: Polymeric drugs for efficient tumortargeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009, 71:409.
6. Li S-D, Huan L: Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer. Biochimica et Biophysica Acta 2009, 1788:2259.
7. Park JW: Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 2002, 4:93.
8. Wang XY, Ishida T, Ichihara M, Kiwada H: Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats. J Control Release 2005, 104:91.
9. Woodle MC, Lasic DD: Sterically stabilized liposomes. Biochim Biophys Acta 1992, 1113:171.
10. Queiroz M-JRP, Abreu AS, Castanheira EMS, Ferreira PMT: Synthesis of new 3-arylindole-2-carboxylates using beta, beta-diaryldehydroamino acids as building blocks. Fluorescence studies. Tetrahedron 2007, 63:2215.
11. Valeur B: Molecular Fluorescence - Principles and Applications. Weinheim: Wiley-VCH; 2002.
12. Lentz BR: Membrane fluidity as detected by diphenylhexatriene probes. Chem Phys Lipids 1989, 50:171.
13. Vincent JS, Revak SD, Cochrane CD, Levin IW: Interactions of model human pulmonary surfactants with a mixed phospholipid-bilayer assembly. Raman spectroscopic studies. Biochemistry 1993, 32:8228.
14. Queiroz M-JRP, Calhelha RC, Vale-Silva LA, Pinto E, Lima RT, Vasconcelos MH: Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle. Eur J Med Chem 2010, 45:5628.
15. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenny S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107.
16. Monks A, Scudiero D, Skehan P, Shoemaker R, Paul K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor-cell lines. J Natl Cancer Inst 1991, 83:757.
17. Queiroz M-JRP, Abreu AS, Carvalho MSD, Ferreira PMT, Nazareth N, Nascimento MS-J: Synthesis of new heteroaryl and heteroannulated indoles from dehydrophenylalanines: Antitumor evaluation. Bioorg Med Chem 2008, 16:5584.
18. Queiroz M-JRP, Calhelha RC, Vale-Silva LA, Pinto E, Nascimento MS-J: Synthesis of novel 3-(aryl)benzothieno[2,3-c]pyran-1-ones from Sonogashira products and intramolecular cyclization: antitumoral activity evaluation. Eur J Med Chem 2009, 44:1893.
19. Castanheira EMS, Abreu AS, Queiroz M-JRP, Ferreira PMT, Coutinho PJG, Nazareth N, Nascimento MS-J: Fluorescence properties of a potential antitumoral benzothieno[3,2-b]pyrrole in solution and lipid membranes. J Photochem Photobiol A: Chem 2009, 206:220.
20. Dupeyre G, Chabot GG, Thoret S, Cachet X, Seguin J, Guénard D, Tillequin F, Scherman D, Koch M, Michel S: Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents. Bioorg Med Chem 2006, 14:4410.
21. Brancale A, Silvestri R: Indole, a core nucleus for potent inhibitors of tubulin polymerization. Medicinal Research Reviews 2007, 27:209.
22. Frederick CA, Williams LD, Ughetto G, van der Marel GA, van Boom JH, Rich A, Wang AH: Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 1990, 29:2538.
23. Mozafari MR, Hasirci V: Mechanism of calcium ion induced multilamellar vesicle DNA interaction. J Microencapsul 1998, 15:55.
24. Ran Y, Yalkowsky SH: Halothane, a novel solvent for the preparation of liposomes containing 2-4'-amino-3'-methylphenyl benzothiazole (AMPB), an anticancer drug. AAPS Pharm Sci Tech 2003, 4:1.
25. Berger N, Sachse A, Bender J, Schubert R, Brandl M: Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. Int J Pharm 2001, 223:55.